HOME >> BIOLOGY >> NEWS
XsalF comes to the fore in brain regionalization

In vertebrates, the nervous system is divided into distinct regions patterned in a head-to-tail direction. Embryologists have long been interested in working out the means by which this regionalization is achieved, and for years the dominant theory has involved a two-step mechanism in which neural tissues are first induced lengthwise down the entire body axis, followed by a transformation step where a second signal specifies the posterior identities of the neural tissue, which can be induced by a number of factors including members of the Wnt and FGF gene families, and retinoic acid.

While there is much evidence to support this model, a number of recent studies have indicated that the specification of the forebrain (an anterior structure, presumed to be induced by the initial signal in the activation-transformation model) requires additional regulatory inputs as well. New work by scientists in the Laboratory for Organogenesis and Neurogenesis (Group Director, Yoshiki Sasai) at the RIKEN Center for Developmental Biology (CDB; Kobe, Japan) showing anterior neural specifying activity in the African clawed frog, Xenopus laevis, lends weight to the revisionist argument.

In an article published in the July 13 issue of Developmental Cell, Takayuki Onai et al. report that XsalF, the Xenopus homolog of spalt, a homeotic gene known to function in anterior-posterior segment identity in Drosophila, regulates the expression of forebrain and midbrain-specific genes. A series of experiments in which XsalF was misexpressed, deleted and its function blocked, showed direct linkage between XsalF expression and forebrain/midbrain identity.

XsalF was originally identified in a screen of the frog anterior neural plate, a structure that appears early in neural development. Sequencing of the gene, and analysis of the timing and spatial pattern of its expression showed that it codes a transcription factor related to Spalt and is expressed in the incipient for
'"/>

Contact: Doug Sipp
sipp@cdb.riken.jp
81-78-306-3043
RIKEN Center for Developmental Biology
12-Jul-2004


Page: 1 2 3

Related biology news :

1. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
2. Scientists characterize new breast tumor subtypes with poor clinical outcomes
3. Rolling Store provides model for overcoming barriers to healthy foods and better health outcomes
4. Moving targets: when it comes to patterns, motion gets factored in
5. When reaper gene comes, cell death follows
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. Clock tells time at such speed that reading it becomes challenge
8. Little yellow molecule comes up big
9. When it comes to sperm competition, size can matterits the female who holds the aces
10. Hopkins scientists reveal how sound becomes electric
11. Researchers identify protein that overcomes leptin resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... today announces publication of a United States multicenter, prospective clinical study that ... disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
Cached News: